Rotateq Dosage & Drug Information

Concise Prescribing Info

Contents

Live, oral pentavalent rotavirus vaccine

Indications/Uses

Prevention of severe rotavirus gastroenteritis in infants & childn.

Dosage/Direction for Use

Vaccination series: 3 doses administered orally to infants. 1st dose should be administered at 6-12 wk of age; subsequent doses should be given at a min interval of 4 wk; 3rd dose should not be given after 32 wk of age.

Administration

May be taken with or without food: Gently squeeze liqd into infant's mouth toward the inner cheek until dosing tube is empty.

Contraindications

Hypersensitivity; individuals who develop symptoms suggestive of hypersensitivity after receiving a dose should not receive further doses. Postpone vaccination in subjects suffering from acute diarrhea or vomiting. Subjects w/ congenital malformations of GIT. Known or suspected immunodeficiency; not recommended to administer in asymptomatic HIV subjects. Severe combined immunodeficiency disease. Previous history of intussusception.

MIMS Class

Vaccines, Antisera & Immunologicals

ATC Classification

J07BH01 - rota virus, live attenuated ; Belongs to the class of rota virus diarrhea viral vaccines.

Regulatory Classification

POM

Presentation/Packing

Form

Rotateq oral soln 2 mL

Packing/Price

1's

Rotateq

rotavirus vaccine

Manufacturer:

MSD